Through a series of in vivo and in vitro experiments, our findings show that LINC01393 upregulates NUSAP1 as a ceRNA inhibiting miR-128-3p, thereby activating NF-κB pathway to promote GBM development and progression. This evidence concerns the gene NFKB1 and glioblastoma.